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Questions regarding T cell development have re-
cently received much attention, but the earliest intra-
thymic differentiation steps in adult mice have re-
mained controversial. Three new papers together
show that for at least some thymus-settling precur-
sors, the loss of B lineage potential occurs in the thy-
mus, and Notch acts on multipotent progenitors early
after thymic entry.
The development of mature blood cell types from
hematopoietic stem cells occurs via a series of inter-
mediate stages with progressive loss of alternate
lineage potentials. Although much is known about the
discrete differentiation steps taken by developing thy-
mocytes and the importance of Notch signaling in this
process, the initial intrathymic events remain elusive.
The earliest population of intrathymic T cell progenitors
is a subset of the DN1 (Lineage-marker-negative CD44+
CD25–) population that expresses high levels of the cy-
tokine receptor c-Kit (Shortman and Wu, 1996; Allman
et al., 2003). These cells are termed early T lineage pro-
genitors (ETPs), and although they comprise less than
0.01% of the adult thymus, emerging evidence indi-
cates that they are functionally and phenotypically
heterogeneous. Understanding this heterogeneity should
provide answers to several controversial questions in T
cell development, which include the identity of thymus-
settling progenitors, whether loss of non-T lineage po-
tentials occurs in progenitors prior to thymic entry, and
the precise role of Notch signaling at these early devel-
opmental stages.
Previous studies indicated that T/NK-restricted pro-
genitors are present in the fetal circulation, even in
athymic nu/nu mice (Rodewald et al., 1994; Carlyle and
Zuniga-Pflucker, 1998). Further, the earliest thymus-col-
onizing cells in day 11–12 fetal mice are restricted to
the T, NK, and DC lineages, and lack B potential (Har-
man et al., 2005; Masuda et al., 2005). Hence, loss of B
lineage potential and restriction to the T/NK/DC lin-
eages occurs prethymically in fetal mice. Whether this
is true in adult mice is unknown. Cells in the most im-
mature thymocyte populations of adult mice possess
non-T lineage potentials, including myeloid, B, NK, and
DC potential (Shortman and Wu, 1996), but it is uncer-
tain whether these alternate potentials derive from
multipotent T lineage progenitors or from separate non-
T progenitor populations. The presence of B potential
in the ETP population has been particularly controver-*Correspondence: bhandooa@mail.med.upenn.edusial. Recent work suggests that the ETP population in
thymus of adult mice contains progenitors with B lin-
eage potential (Allman et al., 2003). Upstream of the
thymus, several multipotent progenitor populations
possessing T and B potential have been identified in
the bone marrow, including cells with a Lineage-
marker-negative Sca-1+ c-Kithi (LSK) phenotype, c-Kitlo
lymphoid-restricted common lymphoid progenitors
(CLP), and B220+ c-Kit− progenitors (CLP-2) (Kondo et
al., 1997; Adolfsson et al., 2001; Martin et al., 2003). The
LSK population has been isolated from blood of adult
mice and thus has access to the thymus (Schwarz and
Bhandoola, 2004), whereas the CLP-2 population has
been shown to efficiently settle in the thymus after in-
travenous delivery (Martin et al., 2003). These data are
consistent with thymic colonization by multipotent pro-
genitors that contain at least T and B potential, and
perhaps additional lineage potentials (hereafter referred
to as T/B multipotent progenitors). However, other re-
cent data have questioned whether T/B multipotent
progenitors can be found in the thymus, instead sug-
gesting that only non-ETP populations within the DN1
subset contain B potential (Porritt et al., 2004; Balciu-
naite et al., 2005). Thus, it is unclear if the adult mouse
thymus is settled by cells possessing B and T progeni-
tor potential or by a mixture of T potent and B potent
cells.
Regardless of the exact properties of adult thymus-
settling cells, the importance of Notch signaling in pro-
moting T cell development is clear. Previous work has
shown that conditional ablation of Notch1 signals leads
to a loss of T cell production and to the development of
B cells in the thymus (Radtke et al., 1999). Conversely,
overexpression of activated Notch1 results in a loss of
B cell production and the appearance of CD4+CD8+ de-
veloping T cells in the bone marrow (Pui et al., 1999).
These results are consistent with two possible scenar-
ios: one in which a multipotent precursor chooses the
T or B lineage depending on the presence or absence
of Notch signals, and another in which the presence or
absence of Notch signals selects for the outgrowth of
T- or B-committed progenitors.
Deciphering the B lineage potential of thymus-
settling T progenitors is thus key to understanding how
and where Notch signals induce T lineage develop-
ment. Recently, three papers have isolated the most im-
mature subset of ETPs in the adult thymus and tested
their lineage potentials. Further, the role of Notch sig-
naling in these early populations has been examined
(Benz and Bleul, 2005; Sambandam et al., 2005; Tan et
al., 2005). The following paragraphs discuss these re-
cent data, focusing first on early progenitors and then
on their requirement for Notch.
To investigate the nature of early intrathymic precur-
sors, Tan et al. used transgenic mice expressing Luna-
tic Fringe (L-Fng) under the control of the thymus-spe-
cific proximal lck promoter (Tan et al., 2005). L-Fng is
a Golgi-localized glycosyltransferase that modifies the
extracellular domains of Notch receptors and alters the
ability of Notch1 to interact with its Delta-like ligand. It
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246was previously shown that the L-Fng transgene de-
creased the ability of precursors to activate Notch1 in
a non-cell-intrinsic manner, resulting in impaired T cell
development and accumulation of intrathymic B cells
(Koch et al., 2001). Thus, the L-Fng transgenic thymus
likely represents an environment in which progenitors
receive weakened Notch1 signals, although the mecha-
nism by which this occurs requires further clarification.
Tan et al. now report that primitive (Lineage-marker-
negative) bone marrow progenitors are affected by this
altered environment but more mature committed pro-
genitors are not. Lineage-marker-negative bone mar-
row progenitors gave rise to more B cells after injection
into the L-Fng thymus compared to the wild-type thy-
mus. In contrast, intrathymic maturation of committed
bone marrow pro-B cells was similar after injection into
L-Fng and wild-type thymi. These data indicate that the
increased numbers of B cells developing in unmanipu-
lated L-Fng transgenic thymi do not derive from com-
mitted B cell progenitors. Instead, these B cells likely
derive from more primitive multipotent progenitors that
make the B versus T decision after entry into the L-Fng
thymus.
Benz and Bleul examined whether multipotent pro-
genitors with T and B potential could be identified
within the adult thymus (Benz and Bleul, 2005). They
began by fractionating ETPs to isolate the most imma-
ture subset and enrich for putative thymus-settling
cells. Using a heterozygous CCR9-EGFP knockin re-
porter mouse, they found that ETPs could be divided
into CCR9-EGFPhi and CCR9-EGFPlo subsets. Further,
the earliest thymus-colonizing cells in the E11.5 fetus
were CCR9-EGFPhi, and a portion of adult bone marrow
LSK cells, CLPs, and c-Kit+ circulating progenitors also
expressed the reporter. From these data, they reasoned
that CCR9-EGFPhi ETPs may be an immature subset of
ETPs, and they confirmed this idea by examining the
kinetics of differentiation of each ETP subset in fetal
thymic organ cultures. CCR9-EGFPhi ETPs were de-
layed in their differentiation to the DN3 stage compared
to CCR9-EGFPlo ETPs, whereas CCR9-EGFPhi circulat-
ing progenitors had slower kinetics than either ETP
subset, but similar to bone marrow progenitors.
Sambandam et al. fractionated ETPs based on ex-
pression of Flt3 (CD135), a cytokine receptor that is ex-
pressed on the nonrenewing fraction of bone marrow
LSK cells, CLPs, and CLP-2 cells, but on only 5%–20%
of the thymic ETP population. In this work, the same
strategy of comparing differentiation kinetics was used
to show that Flt3+ ETPs are less mature than their Flt3lo
counterparts. Moreover, Flt3+ ETPs had greater expan-
sion potential than Flt3lo ETPs upon intrathymic in-
jection.
Both groups then assessed the B lineage potential of
each ETP subset. Benz and Bleul used an in vitro sys-
tem of coculture with OP9 stromal cells to induce B
cell differentiation. B potential was found in the CCR9-
EGFPhi ETP subset. Others have not been able to de-
tect the B lineage potential of ETPs using OP9 cocul-
ture, possibly reflecting variation in the stromal cell
lines used (Porritt et al., 2004; Balciunaite et al., 2005;
Sambandam et al., 2005; Tan et al., 2005). Sambandam
et al. used in vivo assays to show that B lineage poten-
tial was restricted to the Flt3+ ETP subset. Flt3 expres-
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Eion was functionally relevant in that Flt3 ligand was
equired for B cell development from ETPs. However,
lt3 expression was not sufficient to confer B potential
n ETPs, since limiting dilution analyses indicated that
nly a fraction of Flt3+ ETPs contained B potential.
hese data suggest a scenario whereby progenitors
ntering the thymus express Flt3, are CCR9-EGFPhi,
nd contain B potential. As they expand and differenti-
te, they lose B potential and expression of CCR9-
GFP and Flt3, generating a population of downstream
TPs that lacks B progenitor potential (Figure 1).
This model requires that incoming progenitors con-
ain both T and B potential at the single-cell level, rather
han at the population level. Benz and Bleul showed
hat single progenitors with T and B potential are pre-
ent in the thymus, using a clever strategy of mixing
P9 stromal cells with OP9 cells expressing the Notch
igand Delta-like-1 (OP9-DL1), creating a culture system
hat supports B and T cell development from single
rogenitors in the same well. Although colony genera-
ion by single CCR9-EGFPhi cells isolated from the thy-
us was less efficient in this system than on OP9-DL1
ultures (one-tenth of wells plated gave rise to a col-
ny), about 20% of colonies contained CD19+ B cells
nd Thy1+ T cells.
These data imply that there are functional differences
etween early ETPs and late ETPs. Two of the recent
eports also examined the role of Notch signals on thy-
ic populations and found that they are required for
he generation of both early and late ETPs. Unmanipu-
ated L-Fng transgenic thymi have reduced numbers of
TPs and DN2 (Lin– CD44+ CD25+) thymocytes, sug-
esting that Notch signals drive the expansion of these
opulations. Sambandam et al. used retroviral trans-
uction of hematopoietic stem cells with a dominant-
egative Mastermind-like-1 (DNMAML1) construct that
blates signaling from all four Notch receptors. Almost
o DNMAML1+ ETPs were generated, but circulating
NMAML1+ LSK cells were intact, indicating that Notch
ignals are required upstream of ETPs but within the
hymus (Figure 1). Expression analysis in wild-type
hymi revealed that both the Flt3+ and the Flt3lo ETP
ubsets expressed Notch target genes, although at
igher levels in the Flt3lo subset. Flt3 expression was
apidly downregulated from the cell surface when high
evels of Notch signaling were induced in ETPs, consis-
ent with the idea that Notch signals may drive the tran-
ition between Flt3+ ETPs and Flt3lo ETPs. In addition
o potentially driving the transition from early to late
TPs, the requirement for Notch signals in early thymo-
ytes may reflect a prosurvival function of Notch. Con-
istent with this idea, Tan et al. show that in Notch1+/+:
otch1+/− mixed bone marrow chimeras, the ability of
otch1+/− cells to compete declines with each pro-
ressive developmental step in the thymus (Tan et al.,
005).
Although Notch signals are important for driving ETP
eneration and T commitment, they are not completely
ncompatible with B lineage development. The L-Fng
ransgenic system has an intermediate phenotype,
here weak Notch signals in the L-Fng thymus are in-
ufficient for suppression of B lineage development
rom multipotent progenitors and insufficient for normal
TP/DN2 generation, although both processes occur to
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247Figure 1. Model of Early T Cell Development
Circulating progenitors (CP) that include LSK
(Lineagelo Sca-1+ c-Kithi) progenitors with
multilineage potential enter the thymus as
thymus-settling progenitors (TSP). Weak or
short-duration Notch signals cause the loss
of B potential in these precursors. It is also
possible that progenitors lacking B potential
enter the thymus at downstream points. In-
creased intensity or duration of Notch sig-
nals induce the TSP population to expand
and lose the ability to produce B cells, al-
though some of these progenitors may still
express high surface levels of CCR9-EGFP
and Flt3. Further Notch signaling induces a
large expansion of ETPs, which downregu-
late expression of CCR9-EGFP and Flt3.
These Flt3lo CCR9-EGFPlo cells represent
the vast majority of the ETP population.
Notch signals are also required for the tran-
sition to the DN2 stage and subsequent
stages of early thymocyte development. Abbreviations: CP, circulating progenitor; TSP, thymus-settling progenitor; ETP, early T lineage pro-
genitor; DN2, CD4/CD8 double-negative 2; DNMAML1, dominant-negative Mastermind-like-1; L-Fng, Lunatic Fringe transgene. Question
marks denote speculative aspects of this model. Solid red lines denote complete inhibition and dashed red lines denote partial inhibition.some degree. This finding is consistent with in vitro
data from other laboratories. Schmitt et al. titrated a
Notch signaling inhibitor into cocultures of fetal liver
hematopoietic progenitors and OP9-DL1 stroma (Schmitt
et al., 2004). Their data showed that as Notch signals
became stronger (decreasing concentration of inhibi-
tor), B cell development was lost and T cell develop-
ment increased, but intermediate concentrations of in-
hibitor were permissive for B and T development. The
Bernstein group showed that providing low-density
plate bound Notch ligand (DL1) encouraged both B and
T development (Dallas et al., 2005). Unfortunately, it is
not possible to compare levels of Notch signals across
these different experimental systems.
From these recent data, it is clear that Notch signals
are critical at very early steps of intrathymic differentia-
tion and that Notch signals act on T/B multipotent pre-
cursors within the thymus. However, loss of B potential
may not occur immediately after exposure of progeni-
tors to Notch signals. This idea of lagging commitment
has been recently studied in detail using OP9 and OP9-
DL1 cultures (Taghon et al., 2005). Fetal liver progeni-
tors that had received Notch signals for a week and
then were switched to OP9 coculture still retained lim-
ited B potential. These data indicate that the duration
of Notch signaling may be a critical factor in the loss
of alternative lineage potentials. In this regard, much
remains to be learned about where and how Notch sig-
nals are delivered in the thymus. As thymocytes dif-
ferentiate, they migrate through the thymus, presuma-
bly through changing microenvironments. It is not
known if these microenvironments contain variable
levels or types of Notch ligand.
These recent papers advance several aspects of our
knowledge of early T cell development; however, many
uncertainties remain. Although Benz and Bleul have
demonstrated the presence of T/B multipotent precur-
sors in the thymus, such data do not preclude the pos-
sibility that progenitors lacking B lineage potential also
enter the thymus. Indeed, assessment of thymus-hom-
ing cells 24 hr after intravenous injection of bone mar-row showed that c-Kithi progenitors settling in the thy-
mus contained T and NK potential, but failed to give
rise to B lineage cells in vitro (Porritt et al., 2004). It
is possible that loss of B potential in thymus-settling
progenitors occurred rapidly, within the 24 hr between
administration of bone marrow progenitors and analy-
sis of thymic-settling cells. However, a more interesting
possibility is that T/NK-restricted cells enter the thymus
downstream of the Flt3+ CCR9-EGFPhi ETP subset (Fig-
ure 1). Such T/NK-restricted progenitors have not yet
been identified in bone marrow or blood of adult mice,
but substantial heterogeneity exists within bone mar-
row and blood LSK progenitor populations previously
characterized as multipotent (Adolfsson et al., 2001;
Igarashi et al., 2002; Perry et al., 2003; Schwarz and
Bhandoola, 2004). Investigation using single-cell as-
says of progenitor potential may reveal T/NK-restricted
progenitors within various multipotent progenitor pop-
ulations in bone marrow of adult mice. However, the
present demonstration of T/B multipotent progenitors
within the thymus does indicate that prethymically
T/NK restricted progenitors are unlikely to represent the
only pathway of T cell development in adult mice. In-
stead, at least some T/B multipotent progenitors must
settle in the adult thymus.
The identity of multipotent thymus-settling progeni-
tors will likely be further clarified by increasingly so-
phisticated analyses of early thymocyte progenitor
populations at the single-cell level. In this regard, a di-
verse range of bone marrow progenitors with multilin-
eage potential is able to undertake T cell development
when placed in the thymus, including multipotent LSK
cells as well as lymphoid-restricted CLP and CLP-2
cells (Adolfsson et al., 2001; Allman et al., 2003; Martin
et al., 2003). The ability of the thymus to impose the T
lineage fate upon a diverse assortment of progenitors
provides a potential insight into why the site of T cell
development is anatomically isolated from the develop-
mental site of all other blood cells. Such isolation may
be necessitated by the ability of Notch signals to in-
struct a broad range of bone marrow progenitors down
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to speculate that physiological Notch signals that drive
intrathymic T cell development would override develop-
ment of other lineages if they occurred in the bone mar-
row. It follows that the ability to traffic to and settle in
the thymus may separate physiologically relevant T
progenitors from other bone marrow progenitors with T
lineage potential.
Recent work has begun to localize fate choices and
the delivery of Notch signals to specific early thymic
progenitor populations. This information is required to
further study the molecular underpinnings of T cell de-
velopment, and as the field moves closer to the earliest
events occurring in the bone marrow, blood, and the
entry gate of the thymus, additional work will begin to
focus on the necessary steps that precede commit-
ment. Translating observations made in mice to hu-
mans is another tremendous challenge for the future.
So although recent work has given greater definition to
the thymic development model of cellular differentia-
tion, we are left with an area ripe for research.
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